99 research outputs found
Presupernova Structure of Massive Stars
Issues concerning the structure and evolution of core collapse progenitor
stars are discussed with an emphasis on interior evolution. We describe a
program designed to investigate the transport and mixing processes associated
with stellar turbulence, arguably the greatest source of uncertainty in
progenitor structure, besides mass loss, at the time of core collapse. An
effort to use precision observations of stellar parameters to constrain
theoretical modeling is also described.Comment: Proceedings for invited talk at High Energy Density Laboratory
Astrophysics conference, Caltech, March 2010. Special issue of Astrophysics
and Space Science, submitted for peer review: 7 pages, 3 figure
Asteroseismology of Eclipsing Binary Stars in the Kepler Era
Eclipsing binary stars have long served as benchmark systems to measure
fundamental stellar properties. In the past few decades, asteroseismology - the
study of stellar pulsations - has emerged as a new powerful tool to study the
structure and evolution of stars across the HR diagram. Pulsating stars in
eclipsing binary systems are particularly valuable since fundamental properties
(such as radii and masses) can determined using two independent techniques.
Furthermore, independently measured properties from binary orbits can be used
to improve asteroseismic modeling for pulsating stars in which mode
identifications are not straightforward. This contribution provides a review of
asteroseismic detections in eclipsing binary stars, with a focus on space-based
missions such as CoRoT and Kepler, and empirical tests of asteroseismic scaling
relations for stochastic ("solar-like") oscillations.Comment: 28 pages, 12 figures, 2 tables; Proceedings of the AAS topical
conference "Giants of Eclipse" (AASTCS-3), July 28 - August 2 2013, Monterey,
C
Kepler-22b: A 2.4 Earth-radius Planet in the Habitable Zone of a Sun-like Star
A search of the time-series photometry from NASA's Kepler spacecraft reveals
a transiting planet candidate orbiting the 11th magnitude G5 dwarf KIC 10593626
with a period of 290 days. The characteristics of the host star are well
constrained by high-resolution spectroscopy combined with an asteroseismic
analysis of the Kepler photometry, leading to an estimated mass and radius of
0.970 +/- 0.060 MSun and 0.979 +/- 0.020 RSun. The depth of 492 +/- 10ppm for
the three observed transits yields a radius of 2.38 +/- 0.13 REarth for the
planet. The system passes a battery of tests for false positives, including
reconnaissance spectroscopy, high-resolution imaging, and centroid motion. A
full BLENDER analysis provides further validation of the planet interpretation
by showing that contamination of the target by an eclipsing system would rarely
mimic the observed shape of the transits. The final validation of the planet is
provided by 16 radial velocities obtained with HIRES on Keck 1 over a one year
span. Although the velocities do not lead to a reliable orbit and mass
determination, they are able to constrain the mass to a 3{\sigma} upper limit
of 124 MEarth, safely in the regime of planetary masses, thus earning the
designation Kepler-22b. The radiative equilibrium temperature is 262K for a
planet in Kepler-22b's orbit. Although there is no evidence that Kepler-22b is
a rocky planet, it is the first confirmed planet with a measured radius to
orbit in the Habitable Zone of any star other than the Sun.Comment: Accepted to Ap
Seismic analysis of four solar-like stars observed during more than eight months by <i>Kepler</i>
Potencial probiótico in vitro de bactérias åcido-låticas isoladas de queijo-de-minas artesanal da Serra da Canastra, MG
Isolation, enumeration, molecular identification and probiotic potential evaluation of lactic acid bacteria isolated from sheep milk
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.
BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362
Comparison of Newly Isolated Strains of Lactobacillus delbrueckii subsp. lactis for Hydrogen Peroxide Production at 5°C
Gram Negative Bacteria Inhibition by Lactic Acid Culture and Food Preservatives on Catfish Fillets during Refrigerated Storage
Antagonistic Action of Lactobacillus delbrueckii ssp. lactis RM2-5 Toward Spoilage Organisms in Cottage Cheese
- âŠ